AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 03 2017 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
William Heiden, chief executive officer, will present at the
35th Annual J.P. Morgan Healthcare Conference on Tuesday,
January 10, 2017 at 11:30 a.m. Pacific Time (2:30 p.m. Eastern
Time), in San Francisco, California.
A live audio webcast of the presentation and the following
breakout session will be accessible through the Investors section
of the AMAG website at www.amagpharma.com. A replay of the
webcast will be archived on the website until February 11,
2017.
About AMAGAMAG is a biopharmaceutical company
focused on developing and delivering important therapeutics,
conducting clinical research in areas of unmet need and creating
education and support programs for the patients and families we
serve. Our products support the health of patients in the areas of
maternal health, anemia management and cancer supportive care.
Through CBR®, we also help families to preserve newborn stem cells,
which are used today in transplant medicine for certain cancers and
blood, immune and metabolic disorders, and have the potential to
play a valuable role in the ongoing development of regenerative
medicine. For additional company information, please
visit www.amagpharma.com.
AMAG Pharmaceuticals, Inc. Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024